Onco-Innovations Ltd

Onco‑Innovations Ltd’s stock swings reflect the high‑risk, high‑reward nature of biotech, yet its cutting‑edge cancer therapies promise a breakthrough in personalized medicine.

Onco-Innovations Limited has closed a private placement, raising $2 million through the issuance of 1.4 million units at $1.40 per unit, which will be used to support ongoing research and development of its oncology pipeline.

Onco-Innovations Ltd has made significant strides in oncology and data analytics through strategic partnerships and financial restructuring, positioning the company for long-term growth and potential returns on investment.